TTK Healthcare Ltd
TTK Healthcare Limited stands as a prominent healthcare conglomerate in India, operating across multiple strategic business units that span pharmaceuticals, consumer products, medical devices, protective devices, and foods. TTK Healthcare is a part of the TTK Group, a conglomerate of companies operating in various industries. Incorporated in 1958, the company specializes in pharmaceuticals, hospital care products, as well as a consumer products and food division which manufactures shoe polishes and snacks. TTK Healthcare Ltd, incorporated in the year 1958, has its registered office at 6 Cathedral Road, Chennai, Tamil Nadu, 600086, with T T Raghunathan serving as the Chairperson.
TTK Healthcare Limited is an India-based healthcare company. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Others, and Human Pharma. The company has established itself as a trusted name in the healthcare sector, particularly known for its ownership of the famous Woodward's Gripe Water brand, which has been a household name for generations.
The pharmaceuticals division represents one of TTK Healthcare's core business segments. The Pharmaceuticals segment offers products for both human and veterinary use. The Animal Welfare segment includes products for veterinary use. The company's human pharma segment focuses on developing and marketing medications for various therapeutic areas, while the animal welfare division caters to the growing veterinary healthcare market.
TTK Healthcare's consumer products division is well-diversified and includes several popular brands. The Consumer Products segment comprises marketing and distribution of Woodward's Gripe Water, the EVA range of cosmetics, and the good home range of scrubbers and air fresheners. The EVA range of cosmetics and deodorants has been particularly successful, with the company implementing packaging innovations to enhance market appeal.
The medical devices segment showcases TTK Healthcare's commitment to advanced healthcare technology. This segment comprises manufacturing and marketing of artificial heart valves, orthopedic implants, and other related products. Additionally, the Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products.
The foods division represents another strategic business unit for TTK Healthcare. The Foods segment comprises manufacturing and marketing of Food Products. The "Others" segment includes printing and publishing of maps and atlases. This diversification into food products and publishing demonstrates the company's multi-faceted business approach.
TTK Healthcare's financial performance has shown mixed results in recent quarters. For the full year ended March 2025, net profit rose 29.95% to ₹81.66 crore, as against ₹62.84 crore during the previous year ended March 2024. Sales rose 6.47% to ₹801.49 crore in the year ended March 2025, as against ₹752.79 crore during the previous year ended March 2024.
However, the most recent quarterly performance showed some challenges. Net profit of TTK Healthcare declined 11.60% to ₹16.15 crore in the quarter ended March 2025, as against ₹18.27 crore during the previous quarter ended March 2024. Sales rose 5.14% to ₹190.36 crore in the quarter ended March 2025, as against ₹181.06 crore during the previous quarter ended March 2024.
As of May 2025, the market cap of TTK Healthcare Ltd (TTKHLTCARE) is ₹1,817.30 Crore (as of 26th May 2025). The stock has experienced significant volatility, with the 52-week high of TTK Healthcare Ltd (TTKHLTCARE) being ₹1,893.95 and the 52-week low being ₹1,101.05.
Key valuation metrics include:
- The P/E (price-to-earnings) ratio of TTK Healthcare Ltd (TTKHLTCARE) is 22.25.
- The P/B (price-to-book) ratio is 1.82.
- The current dividend yield of TTK Healthcare Ltd (TTKHLTCARE) is 0.78.
TTK Healthcare's stock has experienced mixed performance across different time horizons on BSE:
- Last 1 Month: Share price moved down by 0.38%.
- Last 3 Months: Share price moved up by 3.85%.
- Last 12 Months: Share price moved down by 17.51%.
- Last 3 Years: Share price moved up by 65.90%.
Promoter holding in TTK Healthcare Ltd has remained stable at 74.56% as of March 2025, consistent with June 2024 figures. This stable promoter holding indicates strong management confidence and provides stability to the stock.
TTK Healthcare has established a significant international footprint through strategic partnerships and export operations. Through its agreements with several international corporations such as London International, KaliChemi, and HatuICO Spain, the company exports its products across the world, including to the US, Egypt, UK, Singapore, Malaysia, and the Caribbean.
The company has built strategic collaborations with various foreign corporations, which has enabled it to expand its product portfolio and market reach. These partnerships have been instrumental in the company's growth trajectory and have provided access to advanced technologies and global markets.
TTK Healthcare maintains high operational standards and quality certifications. TTK Healthcare has been certified with ISO 14001 and 9001:2000 standards. These certifications demonstrate the company's commitment to quality management systems and environmental management standards.
The company has undergone strategic restructuring over the years to optimize its operations. This included mergers with M/s Mentholatum India Pvt. Ltd. and TTK Maps and Publications in 1995 and 2000, respectively. To further streamline operations, the paper division of the company and the bulk drugs formulations facility at Hyderabad have been disposed of.
TTK Healthcare presents a diversified investment opportunity in the healthcare sector with its multi-segment business model. An annual revenue growth of 5% is modest, but a healthy pre-tax margin of 11% is noted. The Return on Equity (ROE) of 6% is fair but indicates room for improvement. The company is debt-free and possesses a strong balance sheet, enabling it to report stable earnings growth across business cycles.
The company's strong brand portfolio, particularly the Woodward's Gripe Water brand, provides competitive advantages and market recognition. The diversified business model across healthcare, consumer products, and medical devices offers multiple revenue streams and reduces dependency on any single segment. With stable promoter holding and a debt-free balance sheet, TTK Healthcare continues to position itself as a significant player in India's healthcare industry.
